| 2026 | | Trends in cause-specific mortality among people with and without diabetes in high-income settings: a multinational, population-based study
The lancet. Diabetes & endocrinology, 14(5). : 380-389, 2026 | 김대중 |
| 2026 | | Effect of antidiabetic medication adherence on risk of all-cause mortality and cardiovascular diseases in type 2 diabetes patients: Impact of antidiabetic adherence on cardiovascular disease
Medicine, 105(11). : e48016-e48016, 2026 | 김대중 |
| 2026 | | Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study
The lancet. Diabetes & endocrinology, 14(1). : 20-28, 2026 | 김대중 |
| 2025 | | Psychometric Properties of the Short-Form Revised Lifestyle Evaluation Scale for Metabolic Syndrome–Korean
The science of diabetes self-management and care, 51(6). : 578-588, 2025 | 김대중, 김춘자 |
| 2025 | | Psychometric Evaluation of the Self-Efficacy for Appropriate Medication Use Scale-Korean in People With Diabetes
The science of diabetes self-management and care, 51(5). : 476-486, 2025 | 김대중, 김춘자 |
| 2025 | | Start Early, Do It Well: Implications of a National Diabetes Care Quality Assessment Program for Life Expectancy
Diabetes & metabolism journal, 49(5). : 987-989, 2025 | 김대중 |
| 2025 | | Safety and Effectiveness of Pravastatin in Korean Patients with Dyslipidemia Based on the Cardiovascular Risk Classification: Pooled Analysis of Four Observational Studies
Endocrinology and metabolism (Seoul, Korea), 40(4). : 598-609, 2025 | 김대중 |
| 2025 | | First-year oral antidiabetic adherence and long-term complications in newly diagnosed type 2 diabetes
Diabetes research and clinical practice, 227. : 112405-112405, 2025 | 김대중 |
| 2025 | | Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study
Diabetes & metabolism, 51(5). : 101668-101668, 2025 | 김대중, 하경화, 한승진 |
| 2025 | | Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
International journal of molecular sciences, 26(9). : 4054-4054, 2025 | 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2025 | | Review learning: Real world validation of privacy preserving continual learning across medical institutions
Computers in biology and medicine, 192(Pt B). : 110239-110239, 2025 | 김대중, 박래웅 |
| 2025 | | Medication-Taking Trajectory and Its Correlates in Patients With Diabetes: Based on the Information–Motivation–Behavioral Skills Model
The science of diabetes self-management and care, 51(1). : 100-109, 2025 | 김대중, 김춘자 |
| 2025 | | Effectiveness of gemigliptin on risk of major adverse kidney events in people with type 2 diabetes: A Korean cohort study
Diabetes, obesity & metabolism, 27(4). : 2313-2316, 2025 | 김대중, 하경화 |
| 2025 | | Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study
Journal of diabetes and its complications, 39(5). : 108983-108983, 2025 | 김대중, 하경화 |
| 2025 | | Trends in prescribing sodium-glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular-renal disease in South Korea, 2015–2021
Journal of diabetes investigation, 16(2). : 215-224, 2025 | 김대중, 하경화 |
| 2024 | | Combined impact of prediabetes and hepatic steatosis on cardiometabolic outcomes in young adults
Cardiovascular diabetology, 23(1). : 422-422, 2024 | 김대중, 하경화 |
| 2024 | | Changes in the Epidemiological Landscape of Diabetes in South Korea: Trends in Prevalence, Incidence, and Healthcare Expenditures
Endocrinology and metabolism (Seoul, Korea), 39(5). : 669-677, 2024 | 김대중, 하경화 |
| 2024 | | Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium
The lancet. Diabetes & endocrinology, 12(12). : 915-923, 2024 | 김대중, 하경화 |
| 2024 | | Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
Diabetes & metabolism journal, 48(5). : 837-846, 2024 | 김대중, 전자영 |
| 2024 | | Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease
Endocrinology and metabolism (Seoul, Korea), 39(4). : 622-631, 2024 | 김대중, 하경화 |
| 2024 | | 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Diabetes & metabolism journal, 48(4). : 546-708, 2024 | 김대중, 김혜진 |
| 2024 | | Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells
FASEB journal, 38(15). : e23859-e23859, 2024 | 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2024 | | Efficacy and Safety of Metformin and AtorvastatinCombination Therapy vs. Monotherapy with EitherDrug in Type 2 Diabetes Mellitus and DyslipidemiaPatients (ATOMIC): Double-Blinded RandomizedControlled Trial
Diabetes & metabolism journal, 48(4). : 730-739, 2024 | 김대중 |
| 2024 | | Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study
Korean circulation journal, 54(5). : 256-267, 2024 | 김대중, 하경화 |
| 2024 | | Imeglimin attenuates NLRP3 inflammasome activation by restoring mitochondrial functions in macrophages
Journal of pharmacological sciences, 155(2). : 35-43, 2024 | 김대중, 김혜진, 이관우, 전자영, 한승진 |
| 2024 | | Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations
Journal of diabetes investigation, 15(3). : 285-287, 2024 | 김대중, 하경화 |
| 2023 | | 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Diabetes & metabolism journal, 47(5). : 575-594, 2023 | 김대중, 김혜진 |
| 2023 | | Amphiregulin Induces iNOS and COX-2 Expression through NF- κ B and MAPK Signaling in Hepatic Inflammation
Mediators of inflammation, 2023. : 2364121-2364121, 2023 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2023 | | Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
Cardiovascular diabetology, 22(1). : 233-233, 2023 | 김대중, 하경화 |
| 2023 | | Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea
Diabetes care, 46(9). : 1700-1706, 2023 | 김대중, 하경화 |
| 2023 | | Diet quality partially mediates the association between ultraprocessed food consumption and adiposity indicators
Obesity (Silver Spring, Md.), 31(9). : 2430-2439, 2023 | 김대중, 하경화 |
| 2023 | | Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide population-based cohort study
Diabetes research and clinical practice, 203. : 110820-110820, 2023 | 김대중, 하경화, 한승진 |
| 2023 | | Ultra-Processed Food Consumption and Obesity in Korean Adults
Diabetes & metabolism journal, 47(4). : 547-558, 2023 | 김대중, 하경화 |
| 2023 | | Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study
Diabetes, obesity & metabolism, 25(8). : 2402-2409, 2023 | 김대중 |
| 2023 | | Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients
Endocrinology and metabolism (Seoul, Korea), 38(1). : 139-145, 2023 | 김대중, 김혜진, 박범희, 이관우, 전자영, 한승진 |
| 2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes & metabolism, 49(2). : 101418-101418, 2023 | 김대중, 하경화 |
| 2023 | | Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes
The Korean journal of internal medicine, 38(1). : 93-100, 2023 | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study
Journal of diabetes investigation, 14(3). : 417-428, 2023 | 김대중, 하경화 |
| 2022 | | Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease
Biochemical and biophysical research communications, 588. : 154-160, 2022 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2022 | | Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study
Diabetes care, 45(5). : 1141-1150, 2022 | 김대중, 김혜진, 이관우, 이나미, 전자영, 한승진 |
| 2022 | | Psychometric Properties of the Korean Version of the Perceived Therapeutic Efficacy Scale for Physical Activity in Adults With Type 2 Diabetes
The science of diabetes self-management and care, 48(1). : 11-22, 2022 | 김대중, 김춘자 |
| 2022 | | Association of prediabetes with death and diabetic complications in older adults: The pros and cons of active screening for prediabetes
Age and ageing, 51(6). : afac116-afac116, 2022 | 김대중, 하경화 |
| 2022 | | Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes
Journal of obesity & metabolic syndrome, 31(2). : 187-195, 2022 | 김대중, 하경화 |
| 2022 | | Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022
Diabetes & metabolism journal, 46(6). : 819-826, 2022 | 김대중 |
| 2022 | | Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018 (Diabetes Metab J 2021;45:880-9)
Diabetes & metabolism journal, 46(2). : 349-350, 2022 | 김대중 |
| 2022 | | Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study
Diabetes & metabolism journal, 46(5). : 803-807, 2022 | 김대중, 하경화 |
| 2022 | | Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations
Diabetes & metabolism journal, 46(2). : 273-285, 2022 | 김대중 |
| 2022 | | The Positive Association between Muscle Mass and Bone Status Is Conserved in Men with Diabetes: A Retrospective Cross-Sectional and Longitudinal Study
Journal of clinical medicine, 11(18). : 5370-5370, 2022 | 김대중, 김혜진, 정윤석, 최용준, 한승진 |
| 2022 | | Association between Metabolically Healthy Obesity and Subclinical Atherosclerosis in the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort
Journal of clinical medicine, 11(9). : 2440-2440, 2022 | 김대중, 하경화 |
| 2022 | | Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway
Biomedicines, 10(5). : 1032-1032, 2022 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
